Literature DB >> 19031958

Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients.

Anne-Sophie Gauchez1, Nadia Ravanel, Danièle Villemain, François-Xavier Brand, Dominique Pasquier, Raoul Payan, Mireille Mousseau.   

Abstract

BACKGROUND: Our aim was to conduct an analytical validation in a routine laboratory setting of the cerb-B2/c-neu ELISA assay kit from Calbiochem used to measure the extracellular domain (ECD) of HER2/neu in the serum of breast cancer patients.
MATERIALS AND METHODS: The evaluation was based on three different production lots used in a routine laboratory setting. The reference value was based on a population of 217 patients with breast cancer not overexpressing HER2.
RESULTS: The detection limit, below that given by the manufacturer, was 0.34 ng ml(-1) and the quantification limit was 0.90 ng ml(-1). Reproducibility and repeatability were at least 95%, precision coefficients of variation varied between 6 and 8.5% and trueness measured by dilution tests and the standard additions method varied between 97 and 107%. The threshold was estimated at 5 ng ml(-1).
CONCLUSION: This technique presents satisfactory levels of accuracy for routine laboratory use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031958

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers.

Authors:  LiNa Loo; Joseph A Capobianco; Wei Wu; Xiaotong Gao; Wan Y Shih; Wei-Heng Shih; Kambiz Pourrezaei; Matthew K Robinson; Gregory P Adams
Journal:  Anal Chem       Date:  2011-03-30       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.